Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children

We estimated cost-effectiveness of annually vaccinating children not at high risk with inactivated influenza vaccine (IIV) to range from US $12,000 per quality-adjusted life year (QALY) saved for children ages 6–23 months to $119,000 per QALY saved for children ages 12–17 years. For children at high...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosser, Lisa A., Bridges, Carolyn Buxton, Uyeki, Timothy M., Hinrichsen, Virginia L., Meltzer, Martin I., Molinari, Noelle-Angelique M., Schwartz, Benjamin, Thompson, William W., Fukuda, Keiji, Lieu, Tracy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290928/
https://www.ncbi.nlm.nih.gov/pubmed/17176570
http://dx.doi.org/10.3201/eid1210.051015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290928/
https://www.ncbi.nlm.nih.gov/pubmed/17176570
http://dx.doi.org/10.3201/eid1210.051015

Ejemplares similares